Klor-con and Acthar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Acthar (corticotropin). Common drug interactions include hypoaesthesia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Acthar. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

On Jul, 10, 2026

23 people who take Klor-con and Acthar together, and have interactions are studied.

What are the common drug interactions of Klor-Con and Acthar, by gender? *:

female:

Hypoaesthesia (reduced sense of touch or sensation)
Fall
Balance disorder
Gait disturbance
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Peroneal nerve palsy
Aura
Muscular weakness (muscle weakness)
Fatigue (feeling of tiredness)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

male:

Fatigue (feeling of tiredness)
Cough
Weight decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic kidney disease
Dysphonia (speech disorder attributable to a disorder of phonation)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Memory impairment
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Klor-Con and Acthar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Dizziness
Dyspnoea (difficult or laboured respiration)
Injection site haemorrhage (bleeding from injection site)
Oxygen saturation decreased
Asthenia (weakness)
Bedridden
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Cyst (a closed sac)
Decreased activity

40-49:

Pneumonia

50-59:

Feeling jittery
Insomnia (sleeplessness)
Jugular vein thrombosis (clot in jugular vein)
Pain in extremity
Peripheral swelling
Skin tightness

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Pneumonia
Nausea (feeling of having an urge to vomit)
Renal failure (kidney dysfunction)
Swollen tongue (swelling of tongue)
Vomiting
Bacterial infection
Chronic kidney disease
Dehydration (dryness resulting from the removal of water)
Diarrhoea

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 21.74%
Gait Disturbance: 4 people, 17.39%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 8.70%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 8.70%
Glomerulonephritis Membranous (nephritis with inflammation of the capillary loops in the renal glomeruli): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Acthar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously